Skip to content

Comparing the efficacy of Platelet-Rich Plasma vs. Corticosteroid in Frozen Shoulder

Comparing the Efficacy of Intra-articular Platelet-Rich Plasma, and Corticosteroid Injections in the Management of Frozen Shoulder: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240506061680N1
Enrollment
80
Registered
2024-08-08
Start date
2024-10-22
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesive capsulitis of shoulder. Adhesive capsulitis of shoulder

Interventions

Intervention 1: Intervention group: 8 ml of PRP is injected once. To prepare PRP, 15 ml of the patients blood will be drawn. PRP is prepared using a double-spin centrifugation technique. Blood will be

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Unilateral shoulder pain and limitation of active and passive movements in at least two directions of the glenohumeral joint (abduction, flexion, external rotation, and internal rotation) for more than one month (but less than one year) Age above 18 years Shoulder pain for at least one month with greater than one-third loss of active shoulder flexion, abduction, and external rotation Anterior-posterior normal radiograph of the glenohumeral joint in normal rotation Willingness to participate in the study and forgoing any other treatment method

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study History of previous shoulder trauma/surgery Patients with local infection in the shoulder, systemic infection or inflammatory disease (such as rheumatoid arthritis and hepatitis) Patients with chronic diseases (chronic kidney failure, chronic liver disease) Patients with a history of diabetes or malignancy (hematological or non-hematological) Pregnancy or breastfeeding Patients with blood disorders or under antiplatelet or anticoagulant treatment Drug sensitivity to steroids Taking antitumor or immunosuppressive drugs Corticosteroid injection to the shoulder in the previous 6 months

Design outcomes

Primary

MeasureTime frame
Shoulder pain and disability index score. Timepoint: Before intervention and 3, 6, 12, 24 weeks after the intervention. Method of measurement: Shoulder pain and disability index tool.;The visual analog scale for pain score. Timepoint: Before intervention and 3, 6, 12, 24 weeks after the intervention. Method of measurement: The visual analog scale for pain.;Quick disabilities of the arm, shoulder, and hand questionnaire score. Timepoint: Before intervention and 3, 6, 12, 24 weeks after the intervention. Method of measurement: Quick disabilities of the arm, shoulder, and hand questionnaire.;Joints' range of motion. Timepoint: Before intervention and 3, 6, 12, 24 weeks after the intervention. Method of measurement: Universal goniometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hosein Ebrahimzadeh

Mashhad University of Medical Sciences

ebrahimzadehmh@mums.ac.ir+98 51 3841 7453

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026